Real-time enrollment status for this migraine clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT06602479 |
| Recruiting Status | Recruiting |
| Condition | Migraine |
| Phase | Clinical Trial |
| Target Enrollment | 488 participants |
| Active Locations | 16 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | May 19, 2026 (May 19, 2026) |
As of July 13, 2026: Clinical trial NCT06602479 is currently recruiting participants. This clinical trial study for migraine is actively seeking new participants at 16 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06602479 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06602479 was last updated May 19, 2026 (May 19, 2026). HelloStudys verifies this status automatically.